1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow KeyBioscience AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM Daily injection of KBP/placebo for up to 28 days - Type II Diabetes Mellitus | Phase 1 | Terminated | KeyBioscience AG | 25 | 2018-04-17 | 2020-09-03 |
Germany (1)
Tim Heise, MD (1)